Friday 6 November 2026
Export ENSG’s income statement to Excel — free account
The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
- Revenue
- +14.5%
- EPS
- +23.6%
- Free cash flow
- +89.2%
- Total debt
- +39.2%
Quarter to September 2026, against a year earlier
179.94
2.45
−1.34%
Follow ENSG
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 8 | 7 | 6 |
| 16.88% | 16.90% | 16.96% | 17.03% | ||
| 6.79% | 7.01% | 7.09% | 7.11% | ||
ROIC |
14.73% | 14.64% | 12.90% | 13.42% | |
Return on Tangible Assets |
16.58% | 16.57% | 16.58% | 16.16% | |
Average Days of Receivables |
45.97 | 45.90 | 44.50 | 42.76 | |
Free Cash Flow per Share |
6.47 | 7.03 | 7.23 | 8.82 | |
Free Cash Flow |
370.71 | 406.10 | 419.09 | 509.91 | |
Capital Expenditures |
(193.56) | (186.10) | (189.34) | (185.76) | |
| Other line items | |||||
Cash ROIC |
12.57% | 13.08% | 14.42% | 16.17% | |
Accounts Receivable Turnover |
8.38 | 8.46 | 8.80 | 8.88 | |
Accounts Payable Turnover |
43.39 | 41.94 | 41.41 | 40.96 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
8.34 | 9.56 | 9.48 | 9.67 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.24) | (0.24) | (0.24) | (0.25) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.33% | 5.34% | 5.44% | 5.47% | |
Share Based Compensation of Revenue |
0.95% | 0.98% | 1.02% | 1.09% | |
Interest Coverage |
53.24 | 56.93 | 59.99 | 62.81 | |
Operating CF/Net income |
1.64 | 1.63 | 1.61 | 1.74 | |
Depreciation/Fixed assets |
0.06 | 0.06 | 0.06 | 0.05 | |
Capex/Depreciation |
(1.84) | (1.69) | (1.64) | (1.53) | |
Revenue per Share |
88.26 | 91.29 | 94.67 | 98.13 | |
Operating CF per Share |
9.85 | 10.25 | 10.50 | 12.03 | |
Capex per Share |
(3.38) | (3.22) | (3.27) | (3.21) | |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.03 |
Columns are period end dates · fundamentals updated 2 Nov 2026